EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors

Muhammed Oğuzhan Doğan iD, Begüm Nurpelin Sağlık Özkan iD, Abdullah Burak Karaduman iD, Sevgi Karakuş iD, Yusuf Özkay, Zafer Asım Kaplancıklı iD, Fatih Tok iD

Drug Development Research · 2026-11 · 87 (7)

DOI: 10.1002/ddr.70382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 14.09.2026. Verfasst von Muhammed Oğuzhan Doğan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Hydrazones, Trimetazidine. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Research Council of Turkey, Türkiye Bilimsel ve Teknolojik Araştirma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a progressive neurodegenerative disease, and cholinergic dysfunction is considered one of the fundamental pathological factors of this disease. Guided by the clinically used acetylcholinesterase (AChE) inhibitor donepezil, we explored trimetazidine dihydrochloride as an accessible starting scaffold to generate donepezil‐like features and to develop new anti‐AD candidates. Accordingly, 20 novel hydrazone derivatives were designed and synthesized based on trimetazidine dihydrochloride, and their structures were confirmed by spectroscopic methods. The compounds were evaluated for in vitro inhibition of AChE and butyrylcholinesterase (BChE) using donepezil and tacrine as reference inhibitors, respectively. Several derivatives displayed pronounced AChE inhibition, whereas most compounds showed weak or negligible activity toward BChE, indicating a generally favorable AChE‐selective profile. Among the series, compounds 3p , 3q and 3r exhibited selective inhibitory activity against AChE comparable to donepezil, with IC 50 values of 0.030 ± 0.001 μM, 0.085 ± 0.003 μM and 0.034 ± 0.001 μM, respectively. To rationalize the observed activity trends, molecular docking studies were performed, suggesting that the most active ligands adopt donepezil‐like binding modes spanning the catalytic and peripheral anionic sites and are further stabilized by π–π/π–cation contacts and hydrogen‐bonding interactions within the active gorge. Overall, these findings identify trimetazidine‐derived hydrazide‐hydrazones as a promising chemotype for the development of selective AChE inhibitors and provide a basis for further optimization and advanced biological validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsHydrazonesTrimetazidineMolecular Docking SimulationDrug DesignAcetylcholinesteraseStructure-Activity RelationshipButyrylcholinesteraseHumansDonepezilAlzheimer Disease

Stichwörter der Autor:innen

AChEdonepezilhydrazonein silico studiestrimetazidine

Substanzen

Cholinesterase InhibitorsHydrazonesTrimetazidineAcetylcholinesteraseButyrylcholinesteraseDonepezil

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, İstanbul, Türkiye.
  • Department of Pharmaceutical Chemistry, Institute of Health Sciences, Marmara University, İstanbul, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Türkiye.
  • Central Research Laboratory (MERLAB), Faculty of Pharmacy, Anadolu University, Eskişehir, Türkiye.
  • Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Anadolu University, Eskişehir, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul Aydin University, İstanbul, Türkiye.

ORCID-Profile: Muhammed Oğuzhan Doğan, Begüm Nurpelin Sağlık Özkan, Abdullah Burak Karaduman, Sevgi Karakuş, Zafer Asım Kaplancıklı, Fatih Tok

Förderung

  • Scientific and Technological Research Council of Turkey
  • Türkiye Bilimsel ve Teknolojik Araştirma Kurumu

Zitieren

APA

Doğan, M. O., Özkan, B. N. S., Karaduman, A. B., Karakuş, S., Özkay, Y., Kaplancıklı, Z. A., & Tok, F. (2026). Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors. Drug Development Research, 87(7). https://doi.org/10.1002/ddr.70382

Vancouver

Doğan MO, Özkan BNS, Karaduman AB, Karakuş S, Özkay Y, Kaplancıklı ZA, et al. Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors. Drug Development Research. 2026;87(7). doi:10.1002/ddr.70382

BibTeX
@article{Doan2026,
  author = {Doğan, Muhammed Oğuzhan and Özkan, Begüm Nurpelin Sağlık and Karaduman, Abdullah Burak and Karakuş, Sevgi and Özkay, Yusuf and Kaplancıklı, Zafer Asım and Tok, Fatih},
  title = {Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors},
  journal = {Drug Development Research},
  year = {2026},
  volume = {87},
  number = {7},
  doi = {10.1002/ddr.70382}
}
Kostenlos starten →